-
Ab170476-5mgAducanumab (anti-APP) is a recombinant monoclonal antibody to APP selective for aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.Purity>:95%
-
Ab007318-100μgApplication:CLIA: 1μg/mlELISA: 1μg/ml.
-
Ab007318-10μgApplication:CLIA: 1μg/mlELISA: 1μg/ml.
-
Ab007318-1mgApplication:CLIA: 1μg/mlELISA: 1μg/ml.
-
Ab007318-50μgApplication:CLIA: 1μg/mlELISA: 1μg/ml.
-
Ab087761-100μlMouse anti human AIBZIP Antibody, Monoclonal (1165CT16.1.1), could be used for WB and so on.Application:WB: 1/1000Protein Function:Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but
-
Ab087761-10μlMouse anti human AIBZIP Antibody, Monoclonal (1165CT16.1.1), could be used for WB and so on.Application:WB: 1/1000Protein Function:Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but
-
Ab087761-1mlMouse anti human AIBZIP Antibody, Monoclonal (1165CT16.1.1), could be used for WB and so on.Application:WB: 1/1000Protein Function:Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but
-
Ab087761-50μlMouse anti human AIBZIP Antibody, Monoclonal (1165CT16.1.1), could be used for WB and so on.Application:WB: 1/1000Protein Function:Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but
-
A287763-100mgAkt/SKG Substrate Peptide TFA.
-
A287763-10mgAkt/SKG Substrate Peptide TFA.
-
A287763-1mgAkt/SKG Substrate Peptide TFA.